Alhadrami, H., Sayed, A., Al-Khatabi, H., Alhakamy, N. & Rateb, M. 2021, 'Scaffold hopping of α-rubromycin enables direct access to FDA-approved cromoglicic acid as a SARS-CoV-2 MPro inhibitor', Pharmaceuticals, 14(6), article no: 541. https://doi.org/10.3390/ph14060541